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Objective / To compare four recent guidelines on uncomplicated
cystitis and to examine how cultural factors may have affected
recommendations.
Design / Descriptive study with a qualitative analysis of authors’
reasons for recommendations.
Material / Guidelines for general practitioners published 1999/2000
from Germany, The Netherlands, Norway, and Belgium on diagnosis
and treatment of uncomplicated cystitis. Opinions of the guideline
authors on the influence of local factors on the recommendations were
collected before and after feedback on the differences between the
guidelines.
Results / Few cited references were shared between the guidelines, and
recommendations differed substantially, especially on diagnostic
strategies and referral criteria. The authors attributed parts of the
differences to local factors. German and Belgian authors stressed the
need for safety in their diagnostic and therapeutic approach, while
Dutch authors felt confident in their gatekeeper role and the
Norwegian authors mainly relied on ‘‘the evidence’’. Dutch and
Belgian authors perceived patients to hold power, German authors
referred to the power of the sub-specialists, while the Norwegians
aimed to share power with the patient through a patient-centred
approach.
Conclusion / There are substantial differences even between high-
standard guidelines on the same well-defined clinical entity. The
selection of literature data, and diagnostic and therapeutic recom-
mendations, seemed to be influenced by such cultural aspects as habits,
the patient’s expectations, and the structure of the healthcare system.
Key words: cystitis, guidelines, general practice, uncomplicated lower
urinary tract infection.
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Clinical practice guidelines are in vogue, and so is
evidence-based medicine. Guideline developers should
consider the evidence as well as the existing profes-
sional routines and habits of clinicians to ensure
effective change in clinical practice (1/4). As a result,
the interpretation of the evidence as well as the
recommendations may differ depending on cultural
factors (4). For instance Eisinger et al. found differ-
ences between recommendations from the United
States and France regarding prophylactic mastectomy,
attributable to cultural differences in patient auton-
omy and involvement in healthcare (5). Other studies
comparing guidelines did not study the influence of
cultural factors in detail (6/8).
Acute uncomplicated cystitis in adult women is a
well-defined disorder (9). Nevertheless it is known that
there are important differences in treatment options
with significant impact on antimicrobial resistance
(10). During the period 1999/2000, national guide-
lines on uncomplicated cystitis in general practice were
published in Germany, The Netherlands, Norway, and
Belgium (11/14). All four are evidence-based guide-
lines developed according to recommended procedures
(15). However, we were puzzled by striking differences
between these guidelines.
In this study we compared these four guidelines, and
aimed at describing how the authors perceived the
influence of cultural factors in their guidelines.
MATERIAL AND METHODS
We selected four recent North European guidelines for
general practice targeting similar populations: adult
women with uncomplicated cystitis. The guidelines
Evidence-based guidelines have been developed
in several countries to assist GPs in daily
practice.
. Cultural factors play a role in clinical deci-
sion-making. This study demonstrates that
authors of guidelines are often not aware of
these cultural influences.
. Once confronted with differences between
guidelines from other countries, the guide-
lines’ authors provide scientific arguments as
well as cultural arguments.
. Differences in selection of evidence between
guidelines are striking and need more re-
search.
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were published in 1999 in Germany and The Nether-
lands (11,12) and in 2000 in Norway and Belgium
(13,14). All guidelines were developed by professional
organizations for general practitioners.
We compared the references used in the guidelines
as well as the specific recommendations on diagnosis
and treatment. The authors were asked by e-mail how
they perceived the influence of cultural factors in their
guidelines (‘‘Which cultural influences influenced (a)
the process of guideline development, (b) the formula-
tion of the concrete diagnostic, and (c) the therapeutic
strategy recommended in the guideline?’’). After
having received the answers to these questions, we
confronted the authors with the differences between
the guidelines, and asked them again whether and to
what extent these differences could be attributed to
cultural factors. One of us (TC) was the first author of
the Belgian guideline. Therefore we sent the question-
naires to the second author of this guideline.
In the questionnaire, cultural factors were defined
as ‘‘a mixture of beliefs of patients and practitioners,
local habits, the influence of medical experts from
hospital-based disciplines, expectations of patients,
historical evolutions in medical practice, and organi-
zation of care’’. We have used the concept taking the
same meaning in the following text.
Analysis
Differences in the guidelines are described. The
authors’ explanations for differences between the
guidelines were analysed qualitatively using a prag-
matic approach to Giorgi’s phenomenological method
as modified by Malterud (16). The resulting categories
are presented.
RESULTS
A comparison of the number of references and their
overlap is presented in Table I. Of the 205 literature
citations, only 7 were shared between 3 guidelines, and
only 1 by all 4 guidelines. More references were shared
in the therapeutic sections than in the diagnostic
sections.
The diagnostic recommendations varied from no
further examination in patients with suggestive symp-
toms to always combining illness history with urina-
lysis by use of chemical strip testing or microscopic
examination (Table II). Even the same diagnostic tests
were interpreted differently with important conse-
quences in the proportion of women labelled as having
cystitis.
The drug choice was in agreement in three guide-
lines but with different dosage schedules (see Table II).
The Norwegian guideline did not select a first-choice
drug. Referral strategies also varied. The German
guideline advocated referral of all women with recur-
rence of symptoms, while other guidelines recom-
mended referral only if complicating factors are
suspected (B), or if prophylactic therapy failed (NL).
Authors’ explanations for differences between the
guidelines could by qualitative analysis be broken
down to the following three concepts.
Need for safety
Both German and Belgian authors stressed the need
for safety, i.e. not missing diagnoses, and the need for
adherence to local procedures even if they are not fully
evidence based. Norwegian authors feel confident in
relying on evidence, whereas Dutch authors build their
confidence on their key role in the healthcare system.
. . . the need to exclude even far-fetched, but potentially
serious differential diagnoses. (G)
. . . a general practitioner can not miss a diagnosis. (B)
. . . there has been quite a great resistance against the
recommendation to . . . (but) our recommendations are
based on systematic search of evidence. (N)
. . . guideline development by GPs for GPs. (NL)
Who is perceived as holding power?
German authors described how (sub-)specialists and
their traditions of being on the safe side strongly
influenced the content of the guideline. In contrast,
the Dutch authors claimed that the general practi-
tioners are confident in their contact with patients,
provided that they treat their patients fast and
efficiently. The Belgian authors aimed at anticipating
patients’ reactions in their guideline, while the Norwe-
gian authors believed that evidence-based recommen-
dations might facilitate shared decision-making.
. . . we needed to deal with both the consensus require-
ment (with) and the open access to specialists. (G)
Table I. Distribution of references used in the guidelines
published in Germany (G), The Netherlands (NL), Norway
(N), and Belgium (B).
Total number of references used in the diagnostic section of
the guidelines:
G:14, NL:29, N:9, B:52
Shared references in 4 different guidelines: 1
Shared references in 3 different guidelines: 2
Total number of references used in the therapeutic section
of the guidelines:
G:39, NL:23, N:11, B:28
Shared references in 4 different guidelines: 0
Shared references in 3 different guidelines: 5
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. . . patients can consult without referral a specialist.
This is a very sensitive item with general practitioners
and patients (B)
I personally think it is important . . . (in the case of
uncertainty) . . . to give the patients an opportunity to
participate in the decision-making. (N)
Best evidence for which decision?
Between the countries there were distinct differences in
which recommendations based on ‘‘best evidence’’
were made by authors. While the Norwegian authors
advocated the possibility of no treatment as an
alternative to discuss with the patient, the other
authors discarded this possibility.
We do not have obvious evidence to support a statement
that all uncomplicated UTIs should be treated by
antimicrobials. (N)
There is no evidence that favours non-treatment. Treat-
ment is relatively harmless and cheap, and people do
have complaints. (NL)
Why would she go to the doctor if she doesn’t want
treatment? (G)[In the patients’ view] if a disease is not
cured immediately, it is the fault of the doctor, more
than the natural history of the disease. (B)
Three guidelines (N, NL, B) reported sufficient
evidence for advocating self-initiated treatment for
patients with recurrent cystitis. German and Belgian
Table II. Diagnostic and therapeutic strategies advised in the 4 GP guidelines on uncomplicated lower urinary tract infections.
Germany Netherlands Norway Belgium
DIAGNOSIS
Symptoms/urinalysis Symptoms/urinalysis Symptoms ONLY Symptoms/urinalysis
Urine sample:
No midstream, no cleansing,
spread labia
Urine sample:
Midstream, no cleansing, spread
labia
Urine sample:
NO Urine sample
Urine sample:
Midstream, no cleansing,
spread labia
Urinalysis:
0/ Stick: Nitrite AND LE
N AND LE Pos 0/ UTI
N OR LE Neg 0/ culture
N AND LE Neg 0/ microscopic
detection of bacteria in
unspun urine
Urinalysis:
0/ Stick Nitrite (N)
N Pos 0/ UTI
N Neg 0/ Dipslide culture
OR microscopic detection of
bacteria in urinary sediment
Urinalysis:
NO Urinalysis
Urinalysis:
0/ Stick Nitrite (N)
N Pos 0/ UTI
N Neg 0/ LE-test
N/ AND LE/0/ NO UTI
N/ AND LE/0/ doubt;
ask patient’s preference
Culture:
Only in:
/ Doubts (N OR LE neg)
/ Patients at risk
/ Upper UTI
Culture:
Only in:
/ Complicated UTI
/ Treatment failure of two
antibiotic courses
Culture:
Only in:
/ Treatment failure
/ Recurrent UTI within 4
weeks
/ Risk of complicated UTI
Culture:
Only in:
/ Complicated UTI or pregnancy
/ Recurrent infection
/ Treatment failure
Criterion :/102 cfu/ml Criterion :/104 cfu/ml Criterion:/104 cfu/ml Criterion :/104 cfu/ml
TREATMENT
Selection:
TMP 100 mg 2dd OR
NF 100 mg 2dd
Selection:
TMP 300 mg 1dd
OR NF 50 mg 4dd or 100 mg 2dd
Selection:
NO DRUG SELECTED
Selection:
TMP 300 mg 1dd OR
NF 100 mg 3dd
3 days 3 days 3 days 3 days
Failure:
Change NF to TMP or vice
versa for 10 days
Failure:
Change NF to TMP or vice versa
for 3 days
Failure:
NO recommendations
Failure:
Change NF to TMP or vice versa
for 3 days
Recurrent infections:
TMP or NF at bedtime or
post-coitus For 6 months
Recurrent infections:
TMP or NF nocte or post-coitus
For 3 months OR self-treatment
Recurrent infections:
NO SELECTION
Self-treatment
Recurrent infections:
TMP or NF at bedtime or
post-coitus For 6 months OR
self-treatment
Referral: All Recurrent UTI
(]/3x/year) 0/ urologist
Referral: Failure of prophylactic
therapy in recurrent UTI
Referral: Not mentioned Referral: Only if complicating
factors are suspected in recurrent
UTI
N/nitrite test; LE/leukocyte-esterase test; Pos/positive; Neg/negative; UTI/urinary tract infection; NF/nitrofurantoin;
TMP/trimethoprim.
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authors stated that this practice met with some
resistance from the doctors.
Treatment without investigation of the urine is defend-
able if complaints are clear. . . (NL)
We [doctors] don’t want to leave it completely in the
hands of the patient. (B)
I think there is no sound evidence for self-treatment. . ..
The cultural thing is that self-treatment of any kind is
perceived as very problematic by German doctors. . ..
(G)
DISCUSSION
Our study suggests that cultural factors play a
substantial role in the production of guidelines, both
in selection of literature and in formulation of
recommendations.
The four selected guidelines were all systematically
developed in accordance with accepted strategies (15).
They were developed by expert general practitioners
and peer-reviewed by groups of general practitioners
and external experts, and three of them were tested in
practice. Consequently, the development process was
largely the same for the selected guidelines.
The selected guidelines were ideal for comparison
for references as they addressed the same disease, and
were all published within the same period. The
systematic literature search described by the authors
was rather similar, so the potential sources of evidence
were shared. Nevertheless, there was little overlap in
evidence cited by the guidelines. This illustrates that
other factors, beyond the guideline development
process, may influence the selection of evidence.
Authors of the guidelines seemed to select literature
that was most in accordance with the local conditions
and their norms and values. Consequently, ‘‘guidelines
for guidelines’’ do not guarantee a standardized out-
come.
Most differences between the guidelines were found
in the diagnostic recommendations. This divergence
may partly be due to the lack of diagnostic trials in
general practice (17). Most available data come from
microbiological studies, which cannot be extrapolated
to general practice. Even the definition of UTI in a
clinical setting is controversial. Only symptoms as well
as results of urinalysis or urine culture may be used as
criteria (9,18). When there are conflicting definitions
and lack of evidence, local traditions in the healthcare
system could influence the decisions on diagnostic
procedures. For instance, in Norway diagnosis by
telephone was optional, as typical symptoms alone
were regarded as sufficient for the diagnosis (13).
Others have recently supported this standpoint (9,18).
The Norwegian authors also considered this as
empowering the patient. Relying on symptoms alone
was not acceptable for German or Belgian GPs: they
felt need for more ‘‘safety’’ in the diagnostic process
and therefore advocated urinalysis and other diagnos-
tic tests for diagnosing UTI. In Belgium, patients
expect home visits by their GP, and a diagnostic
strategy feasible at home was preferred (19).
For the therapy of uncomplicated UTI a large
number of trials indicate the effectiveness of a variety
of drugs. Therefore the ultimate choice of the first-line
drug is based on consensus. The Norwegian guideline
did not recommend any specific drug and left the
choice to the individual GP. In Germany, The Nether-
lands, and Belgium, the same choice was made for 3
days’ treatment with TMP and NF, illustrating more a
Northern European consensus on well-known and
cheap drugs rather than strong evidence (20).
Self-treatment was an option in all guidelines except
the German, in the case of recurrent cystitis. The
German guideline recommended referral to a urologist
instead. This may also be an illustration of the need
for safety.
Both needs for safety and perception of who holds
power may be influenced by the healthcare system. In
The Netherlands and Norway, the GP is a ‘‘gate-
keeper’’ and patients can only consult a specialist after
referral by a GP. Both Dutch and Norwegian authors
displayed the self-confidence of GPs in their answers.
The Dutch authors focused on their role in the system,
while the Norwegian authors focused on staying
evidence-based and on building grounds for patient-
centred strategies. In contrast, Belgian and German
GPs are subjected to a system where patients may
freely consult other specialists. This may have resulted
in a more defensive attitude in the guideline (21),
especially in the diagnostic recommendations and
referral criteria.
The interaction between the two factors ‘‘need for
safety’’ and ‘‘perception of who holds power’’ may
depend heavily on local conditions. Authors of the
German and the Belgian guidelines perceived the
differences to stem from pressure: from the sub-
specialists in Germany and from the patients in
Belgium, respectively. The Dutch and the Norwegian
authors stated that their argumentation was evidence-
based, but still results differed.
Our data clearly illustrate how the same evidence
may be used for diametrically opposite conclusions
depending on the authors’ conceptual framework. The
impact of current best evidence was used to support
the recommendation that all patients with uncompli-
cated cystitis should be treated, while its limitations
were used to justify the option of no treatment. The
144 T. Christiaens et al.
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specific evidence-based pros and cons seemed to arise
from conceptions of what was desirable or possible
under local conditions. This may be a general diffi-
culty in any guideline development. Rogers, in a recent
paper on guidelines and ethics, points to the impor-
tance of the priority-setting process, and points out
that we need a way of setting priorities in an explicit
and transparent process as the effects of group
composition on final recommendations are well docu-
mented (22,23).
The transparency of a guideline is improved by
providing levels of evidence and grades of recommen-
dations (24), as in the German and Norwegian guide-
lines. If the recommendations are based on consensus
or expert opinion, the supportive arguments could be
explicitly described in the text. This might help the
guideline user to distinguish evidence-based from
culture-based statements. Another possibility for im-
provement is to adopt an external review asking
guideline developers in other countries to comment
on draft guidelines in order to explore the cultural and
local influences (23). In particular, if existing interna-
tional guidelines are used for local adaptation, as
recently proposed by Bro and Waldorff for the
Scandinavian countries, there is a strong need for
transparency (25).
Finally, international collaboration in guideline
production, as in Cochrane groups or international
scientific societies, may increase the possibility to
disclose cultural influences. Once disclosed, differences
could be worked on, or the authors could at least keep
track of them in the guideline.
In conclusion, there are substantial differences even
between high-standard guidelines on the same well-
defined clinical entity. The selection of literature data,
and diagnostic and therapeutic recommendations,
seemed to be influenced by such cultural aspects as
habits, the patient’s, expectations and the structure of
the healthcare system.
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